{"id":"W4200504528","doi":"10.1158/1535-7163.mct-21-0615","title":"RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors","year":2021,"lang":"en","type":"letter","venue":"Molecular Cancer Therapeutics","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cégep de Saint-Laurent; Telesta Therapeutics (Canada); Aegera Therapeutics (Canada)","funders":"","keywords":"Kinase; Olaparib; Pharmacology; In vivo; DNA damage; PARP inhibitor; PI3K/AKT/mTOR pathway; Cancer research; Chemistry; Biology; Biochemistry; Signal transduction; DNA; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003410161,0.0008206949,0.001293454,0.000553044,0.00007606114,0.0001093956,0.0001391065,0.001266112,0.00002586376],"category_scores_gemma":[0.00001453402,0.0007675933,0.0001746236,0.0007625483,0.0003745415,0.0002025493,0.00007285843,0.002669179,0.0000019025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001018439,"about_ca_system_score_gemma":0.0006717297,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005584962,"about_ca_topic_score_gemma":0.0002389486,"domain_scores_codex":[0.9959915,0.000413838,0.0006679162,0.001404058,0.0008538332,0.0006688747],"domain_scores_gemma":[0.9983562,0.0002775974,0.0003897884,0.0005396734,0.0002976253,0.0001390913],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.05595026,0.01025447,0.1915472,0.009518212,0.02659278,0.01980134,0.07007995,0.003453066,0.2384877,0.0006323247,0.07971308,0.2939696],"study_design_scores_gemma":[0.1524664,0.01227856,0.02174245,0.02559229,0.003960288,0.00181474,0.001322489,0.01491983,0.4981757,0.01632114,0.2433088,0.008097304],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5880611,0.03883379,0.003346041,0.362054,0.0005297603,0.006372121,0.0001903433,0.0001313403,0.0004814635],"genre_scores_gemma":[0.5149267,0.00757569,0.0007239834,0.4737989,0.0006095039,0.001656149,0.000149252,0.0003079851,0.000251859],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2858723,"threshold_uncertainty_score":0.9996317,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04383461660618057,"score_gpt":0.3300402038009939,"score_spread":0.2862055871948133,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}